Back to Agenda
Global Perspectives on Patient Engagement
Session Chair(s)
Mathieu Boudes, PhD
Patient Engagement Director
Montsouris Consilium, France
In Europe and North America, patient engagement in drug development is now expected, though not perfect. In this session, a panel of patient, industry, and regulator stakeholders will discuss the thinking and initiatives in other global regions to give patients a voice. We will look beyond Europe and North America to explore the thinking and efforts in other regions to engage patients in the medical product lifecycle. What efforts are underway or emerging to give patients a voice? What cultural, societal, and economic factors drive current thoughts and practices? Who are the influencers who are encouraging change? A diverse panel representing patient groups, regulators and industry from regions such as Asia and Latin America will talk about current experience, hopes, and aspirations for patient engagement worldwide.
Learning Objective : Describe current practices for patient engagement in drug development and regulation in regions such as Asia and Latin America; Compare and contrast perspectives of patient, industry, and regulator stakeholders within these regions; Discuss cultural, societal, and other factors playing a role in views, practices, and emerging trends on patient engagement in these regions.
Speaker(s)
Panelist
Junko Sato, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director
Panelist
Jan Nissen, BSN, MBA, MS
Consultant, United States
Former, Vice President, Patient Innovation and Engagement, Merck & Co., Inc.
Panelist
Durhane Wong-Rieger, PhD, MA
Canadian Organization For Rare Disorders, Canada
President and Chief Executive Officer
Panelist
Young Jack Lee, PhD
LSK Global Pharma Services, Korea, Republic of
Chief Executive Officer
Panelist
Jieun Lee, RPh
Ministry of Food and Drugs Safety, Korea, Republic of
Assistant Director
Have an account?